Pharmaceutical Executive Daily: FDA Approves Wegovy Pill

Pharmaceutical Executive Daily: Nine New Additions to TrumpRx

Scaling Sustainability: A Big Pharma Formula

Pharmaceutical Executive Daily: US Senate Passes Biosecure Act

Pharmaceutical Executive Daily: Pfizer's Stock Drops Following 2026 Revenue Projections Release

Pharmaceutical Executive Daily: FDA's Approval of Lerochol

Pharmaceutical Executive Daily: TrumpRx's Critical Blind Spot

Pharmaceutical Executive Daily: Retatrutide's Positive Phase III Trial Results

Pharmaceutical Executive Daily: FDA's Approval of Waskyra

Pharmaceutical Executive Daily: FDA's New Standard for CAR-T Approvals

Pharmaceutical Executive Daily: Carvykti Demonstrates Sustained Remissions

Pharmaceutical Executive Daily: FDA Approves Breyanzi

Pharmaceutical Executive Daily: Mark Cuban's Push for Generic Drug Fee Waivers

Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER

Pharmaceutical Executive Daily: FDA's Agentic AI Deployment

Pharmaceutical Executive Daily: Lilly Reduces the Price of Zepbound

Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products

Pharmaceutical Executive Daily: Novartis Cuts 550 Jobs

Pharmaceutical Executive Daily: Moderna's $1.5 Billion Loan

Pharmaceutical Executive Daily: Tesaro and AnaptysBio's Legal Battle